Chronic Wound Care (Autologous Fat & Stem Cell)

For non-healing wounds, Cellthera combines wound debridement with the patient's own fat and adipose-derived stem cells to support tissue repair. After cleaning and preparing the wound, the clinic applies autologous fat and concentrated regenerative cells, which are associated with reducing inflammation, stimulating new blood-vessel formation and supporting healing of the surrounding tissue. The approach is offered for chronic wounds that have failed to close with standard care, drawing on the same SVF cell platform and PRP techniques used across the clinic's regenerative services, and the number of treatments is tailored to the wound.

Chronic-wound care at Cellthera applies the clinic's regenerative platform to wounds that have failed to heal with conventional treatment. The rationale is that adipose-derived stem cells and the growth factors in fat and platelet-rich plasma are associated with dampening chronic inflammation, promoting angiogenesis (the growth of new blood vessels) and supporting the repair of damaged skin and soft tissue — all of which are limiting factors in wounds that will not close. A course typically begins with assessment of the wound and the underlying cause, followed by debridement to remove dead or infected tissue and prepare a clean wound bed. The clinic then applies autologous fat together with adipose-derived stem cells, and may use platelet-rich plasma, to deliver regenerative material directly to the wound and surrounding tissue. Because the fat and cells come from the patient, this draws on the same harvesting and SVF-processing capability used in the clinic's joint and aesthetic work. The number and spacing of treatments depend on the wound's size, depth and cause. This service is aimed at people with chronic, slow-healing wounds such as venous leg ulcers, ulcers associated with lymphedema, diabetic neuropathic foot ulcers and pressure sores (decubitus). It is generally considered when standard wound care has not produced adequate healing. Suitability and the underlying condition (for example circulation or diabetes control) are reviewed at consultation, and the clinic screens for contraindications including uncontrolled infection and malignancy. Healing is gradual and depends heavily on managing the underlying cause alongside the regenerative treatment; outcomes are individual and presented as supportive of healing rather than guaranteed.